Variability and uncertainty of 18F-FDG PET imaging protocols for assessing inflammation in atherosclerosis: Suggestions for improvement

Journal of Nuclear Medicine

Volumn 56, Issue 4, 2015, Pages 552-559

  Huet, Pauline ^a,b   Burg, Samuel ^c   Le Guludec, Dominique ^c   Hyafil, Fabien ^c   Buvat, Irène ^a  

^a INSERM   (France)

^b Centre National de la Recherche Scientifique   (France)

^c ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

Author keywords

18F FDG PET; Atherosclerosis; Partial volume effect; Vascular lesions

Indexed keywords

FLUORODEOXYGLUCOSE F 18; RADIOPHARMACEUTICAL AGENT;

ARTICLE; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CARDIAC IMAGING; CARDIOVASCULAR PARAMETERS; CLINICAL PROTOCOL; CONTROLLED STUDY; DATA ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DISEASE ASSOCIATION; HUMAN; IMAGE ANALYSIS; IMAGE PROCESSING; IMAGE RECONSTRUCTION; MEDICAL RESEARCH; OUTCOME ASSESSMENT; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; STANDARDIZED UPTAKE VALUE; TARGET TO BLOOD ACTIVITY RATIO; UNCERTAINTY; VASCULITIS; ALGORITHM; CAROTID ARTERY; COMPUTER ASSISTED TOMOGRAPHY; COMPUTER SIMULATION; DIAGNOSTIC USE; INFLAMMATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PROCEDURES; REPRODUCIBILITY; SCINTISCANNING; STATISTICAL MODEL;

ALGORITHMS; ATHEROSCLEROSIS; CAROTID ARTERIES; COMPUTER SIMULATION; FLUORODEOXYGLUCOSE F18; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; INFLAMMATION; LIKELIHOOD FUNCTIONS; MAGNETIC RESONANCE IMAGING; PLAQUE, ATHEROSCLEROTIC; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; REPRODUCIBILITY OF RESULTS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84928266682     PISSN: 01615505     EISSN: 2159662X     Source Type: Journal    
DOI: 10.2967/jnumed.114.142596     Document Type: Article

References (40)

1. Rudd JHF, Hyafil F, Fayad Z. Inflammation imaging in atherosclerosis. Arterioscler Thromb Vasc Biol. 2009;29:1009-1016.
2. Orbay H, Hong H, Zhang Y, Cai W. Positron emission tomography imaging of atherosclerosis. Theranostics. 2013;3:894-902.
3. Cheng Y, Ly N, Wang Z, Chen D, Dang A. 18-FDG-PET in assessing disease activity in Takayasu arteritis: a meta-analysis. Clin Exp Rheumatol. 2013;31:S22-S27.
4. Hope MD, Hope TA. Functional and molecular imaging techniques in aortic aneurysm disease. Curr Opin Cardiol. 2013;28:609-618.
5. Erlandsson K, Buvat I, Pretorius PH, Thomas B, Hutton BF. A review of partial volume correction techniques for emission tomography and their applications in neurology, cardiology and oncology. Phys Med Biol. 2012;57:R119-R159.
6. Soret M, Bacharach SL, Buvat I. Partial-volume effect in PET tumor imaging. J Nucl Med. 2007;48:932-945.
7. Burg S, Dupas A, Stute S, et al. Partial volume effect estimation and correction in the aortic vascular wall in PET imaging. Phys Med Biol. 2013;58:7527-7542.
8. Segars WP, Sturgeon G, Mendonca S, Grimes J, Tsui BMW. 4D XCAT phantom for multimodality imaging research. Med Phys. 2010;37:4902-4915.
9. Avolio AP. Multi-branched model of the human arterial system. Med Biol Eng Comput. 1980;18:709-718.
10. Michel J-B, Thaunat O, Houard X, Meilhac O, Caligiuri G, Nicoletti A. Topological determinants and consequences of adventitial responses to arterial wall injury. Arterioscler Thromb Vasc Biol. 2007;27:1259-1268.
11. Woodard HQ. The composition of body tissue. Br J Radiol. 1986;59:1209-1218.
12. Jan S, Benoit D, Becheva E, et al. GATE V6: a major enhancement of the GATE simulation platform enabling modelling of CT and radiotherapy. Phys Med Biol. 2011;56:881-901.
13. Stute S, Vauclin S, Necib H, et al. Realistic and efficient modeling of radiotracer heterogeneity in Monte Carlo simulations of PET images with tumors. IEEE Trans Nucl Sci. 2012;59:113-122.
14. Michel C, Sibomanal M, Boll A, et al. Preserving Poisson characteristics of PET data with weighted OSEM reconstruction. IEEE Nucl Sci Symp Conf Rec. 1998;2:1323-1329.
15. Sureau FC, Reader AJ, Comtat C, et al. Impact of image-space resolution modeling for studies with the high-resolution research tomograph. J Nucl Med. 2008;49:1000-1008.
16. Ripa RS, Knudsen A, Hag AMF, Lebech A, Loft A, Sune H. Feasibility of simultaneous PET/MR of the carotid artery: first clinical experience and comparison to PET/CT. Am J Nucl Med Mol Imaging. 2013;3:361-371.
17. Rogers IS, Nasir K, Figueroa AL, et al. Feasibility of FDG imaging of the coronary arteries: comparison between acute coronary syndrome and stable angina. JACC Cardiovasc Imaging. 2010;3:388-397.
18. 18F-FDG uptake in arterial atheroma on PET/CT? Implications for imaging the vulnerable plaque. Atherosclerosis. 2010;211:136-140.
19. 18F-FDG uptake and arterial wall calcifications using 18F-FDG PET/CT. J Nucl Med. 2004;45:1816-1821.
20. Ben-Haim S, Kupzov E, Tamir A, Frenkel A, Israel O. Changing patterns of abnormal vascular wall F-18 fluorodeoxyglucose uptake on follow-up PET/CT studies. J Nucl Cardiol. 2006;13:791-800.
21. Tatsumi M, Cohade C, Nakamoto Y, Wahl RL. Fluorodeoxyglucose uptake in the aortic wall at PET/CT: possible findings for active atherosclerosis. Radiology. 2003;229:831-837.
22. Paulmier B, Duet M, Khayat R, et al. Arterial wall uptake of fluorodeoxyglucose on PET imaging in stable cancer disease patients indicates higher risk for cardiovascular events. J Nucl Cardiol. 2008;15:209-217.
23. Davies JR, Rudd JHF, Fryer TD, et al. Identification of culprit lesions after transient ischemic attack by combined 18F fluorodeoxyglucose positron-emission tomography and high-resolution magnetic resonance imaging. Stroke. 2005;36:2642-2647.
24. Rudd JHF, Warburton EA, Fryer TD, et al. Imaging atherosclerotic plaque inflammation with [18F]-fluorodeoxyglucose positron emission tomography. Circulation. 2002;105:2708-2711.
25. Izquierdo-Garcia D, Davies JR, Graves MJ, et al. Comparison of methods for magnetic resonance-guided [18-F]fluorodeoxyglucose positron emission tomography in human carotid arteries: reproducibility, partial volume correction, and correlation between methods. Stroke. 2009;40:86-93.
26. Tahara N, Kai H, Nakaura H, et al. The prevalence of inflammation in carotid atherosclerosis: analysis with fluorodeoxyglucose-positron emission tomography. Eur Heart J. 2007;28:2243-2248.
27. 18F-FDG uptake with plasma high-density lipoprotein elevation by atherogenic risk reduction. J Nucl Med. 2008;49:1277-1282.
28. Bucerius J, Duivenvoorden R, Mani V, et al. Prevalence and risk factors of carotid vessel wall inflammation in coronary artery disease patients: FDG-PET and CT imaging study. JACC Cardiovasc Imaging. 2011;4:1195-1205.
29. Bural GG, Torigian D, Chamroonrat W, et al. Quantitative assessment of the atherosclerotic burden of the aorta by combined FDG-PET and CT image analysis: a new concept. Nucl Med Biol. 2006;33:1037-1043.
30. Tahara N, Kai H, Ishibashi M, et al. Simvastatin attenuates plaque inflammation: evaluation by fluorodeoxyglucose positron emission tomography. J Am Coll Cardiol. 2006;48:1825-1831.
31. 18F-fluorodeoxyglucose positron emission tomography uptake. J Am Coll Cardiol. 2012;59:2080-2088.
32. 18F-FDG PET: carotid, iliac, and femoral uptake reproducibility, quantification methods, and recommendations. J Nucl Med. 2008;49:871-878.
33. Fayad ZA, Mani V, Woodward M, et al. Safety and efficacy of dalcetrapib on atherosclerotic disease using novel non-invasive multimodality imaging (dal-PLAQUE): a randomised clinical trial. Lancet. 2011;378:1547-1559.
34. Rousset OG, Ma Y, Evans AC. Correction for partial volume effects in PET: principle and validation. J Nucl Med. 1998;39:904-911.
35. Petibon Y, El Fakhri G, Nezafat R, Johnson N, Brady T, Ouyang J. Towards coronary plaque imaging using simultaneous PET-MR: a simulation study. Phys Med Biol. 2014;59:1203-1222.
36. Calcagno C, Ramachandran S, Izquierdo-Garcia D, et al. The complementary roles of dynamic contrast-enhanced MRI and 18F-fluorodeoxyglucose PET/CT for imaging of carotid atherosclerosis. Eur J Nucl Med Mol Imaging. 2013;40:1884-1893.
37. 18F-fluorodeoxyglucose positron emission tomography predicts early stroke recurrence. Ann Neurol. 2012;71:709-718.
38. 18F-FDG accumulation in atherosclerosis: use of CT and MR co-registration of thoracic and carotid arteries. Eur J Nucl Med Mol Imaging. 2006;33:589-594.
39. 18F-FDG PET/CT angiography of carotid plaque with immunohistochemical validation. J Nucl Med. 2011;52:1698-1703.
40. 18F-fluoride positron emission tomography for identification of ruptured and high-risk coronary atherosclerotic plaques: a prospective clinical trial. Lancet. 2014;383:705-713.